Literature DB >> 1675791

Cloning and expression of the human vasoactive intestinal peptide receptor.

S P Sreedharan1, A Robichon, K E Peterson, E J Goetzl.   

Abstract

Vasoactive intestinal peptide (VIP) is a neuroendocrine mediator found in the central and peripheral nervous system. Distinct subsets of neural, respiratory, gastrointestinal, and immune cells bear specific high-affinity receptors for VIP, which are associated with a guanine nucleotide-binding (G) protein capable of activating adenylate cyclase. A cDNA clone (GPRN1) encoding the human VIP receptor was identified in libraries prepared from the Nalm 6 line of leukemic pre-B lymphoblasts and the HT-29 line of colon carcinoma cells. The deduced 362-amino acid polypeptide sequence encoded by GPRN1 shares a seven-transmembrane-segment hydropathicity profile with other G protein-coupled receptors. Northern blot analyses identified a 2.7-kilobase transcript of the VIP receptor in Nalm 6 and HT-29 cells as well as in tissues from rat brain, colon, heart, lung, kidney, spleen, and small intestine. COS-6 cells transfected with GPRN1 bound 125I-labeled VIP specifically with a dissociation constant (Kd) of 2.5 nM. VIP--and less effectively secretin, peptide histidine isoleucine (PHI), and glucagon competitively displaced bound 125I-VIP from transfected COS-6 cells, with potencies in the order VIP greater than secretin = PHI much greater than glucagon. VIP stimulated adenylate cyclase activity in stably transfected Chinese hamster ovary K1 cells, inducing a 3-fold increase in the intracellular level of cAMP. When the antisense orientation of the VIP receptor clone was introduced into HT-29 cells, there was a 50% suppression of the specific binding of 125I-VIP and of the VIP-induced increase in cAMP level, relative to untransfected cells. The VIP receptor cloned exhibits less than or equal to 24% homology with other receptors in the same superfamily and thus represents a subset of G protein-coupled receptors for peptide ligands.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1675791      PMCID: PMC51792          DOI: 10.1073/pnas.88.11.4986

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Selective effects of cholera toxin on the activation of mouse B cells by different polyclonal activators.

Authors:  G G Klaus; K Vondy; M Holman
Journal:  Eur J Immunol       Date:  1987-12       Impact factor: 5.532

2.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure.

Authors:  P L Felgner; T R Gadek; M Holm; R Roman; H W Chan; M Wenz; J P Northrop; G M Ringold; M Danielsen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Selective amplification and cloning of four new members of the G protein-coupled receptor family.

Authors:  F Libert; M Parmentier; A Lefort; C Dinsart; J Van Sande; C Maenhaut; M J Simons; J E Dumont; G Vassart
Journal:  Science       Date:  1989-05-05       Impact factor: 47.728

4.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

Authors:  R K Saiki; S Scharf; F Faloona; K B Mullis; G T Horn; H A Erlich; N Arnheim
Journal:  Science       Date:  1985-12-20       Impact factor: 47.728

5.  Polypeptide with broad biological activity: isolation from small intestine.

Authors:  S I Said; V Mutt
Journal:  Science       Date:  1970-09-18       Impact factor: 47.728

6.  A small multigene family encodes Gi signal-transduction proteins.

Authors:  C R Beals; C B Wilson; R M Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

7.  Vasoactive intestinal polypeptide stimulates cell proliferation and adenylate cyclase activity of cultured human keratinocytes.

Authors:  A Haegerstrand; B Jonzon; C J Dalsgaard; J Nilsson
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

8.  Molecular cloning of the fMet-Leu-Phe receptor from neutrophils.

Authors:  K M Thomas; H Y Pyun; J Navarro
Journal:  J Biol Chem       Date:  1990-11-25       Impact factor: 5.157

9.  Structural basis of beta-adrenergic receptor function.

Authors:  C D Strader; I S Sigal; R A Dixon
Journal:  FASEB J       Date:  1989-05       Impact factor: 5.191

10.  Unique pattern of cleavage of vasoactive intestinal peptide by human lymphocytes.

Authors:  E J Goetzl; K T Kodama; C W Turck; S A Schiogolev; S P Sreedharan
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

View more
  18 in total

1.  Antitumorigenic actions of growth hormone-releasing hormone antagonists.

Authors:  R D Kineman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

2.  RDCI, the vasoactive intestinal peptide receptor: a candidate gene for the features of Albright hereditary osteodystrophy associated with deletion of 2q37.

Authors:  M M Power; R S James; J C Barber; A M Fisher; P J Wood; B A Leatherdale; D E Flanagan; E Hatchwell
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

4.  Expression cloning of an ATP receptor from mouse neuroblastoma cells.

Authors:  K D Lustig; A K Shiau; A J Brake; D Julius
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

5.  Expression cloning of a human corticotropin-releasing-factor receptor.

Authors:  R Chen; K A Lewis; M H Perrin; W W Vale
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

6.  A putative G protein-coupled receptor, RDC1, is a novel coreceptor for human and simian immunodeficiency viruses.

Authors:  N Shimizu; Y Soda; K Kanbe; H Y Liu; R Mukai; T Kitamura; H Hoshino
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Inhibition by vasoactive intestinal polypeptide (VIP) of angiogenesis induced by murine Colon 26-L5 carcinoma cells metastasized in liver.

Authors:  M Ogasawara; J Murata; Y Kamitani; K Hayashi; I Saiki
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

8.  CD10/NEP in non-small cell lung carcinomas. Relationship to cellular proliferation.

Authors:  R K Ganju; M Sunday; D G Tsarwhas; A Card; M A Shipp
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog.

Authors:  Mathew L Thakur; Mohan R Aruva; Jean Gariepy; Paul Acton; Satish Rattan; Shyam Prasad; Eric Wickstrom; Abass Alavi
Journal:  J Nucl Med       Date:  2004-08       Impact factor: 10.057

10.  Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension.

Authors:  Ventzislav Petkov; Wilhelm Mosgoeller; Rolf Ziesche; Markus Raderer; Leopold Stiebellehner; Karin Vonbank; Georg-Christian Funk; Gerhard Hamilton; Clemens Novotny; Bernhard Burian; Lutz-Henning Block
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.